A CLINICAL CASE STUDY OF HEPATITIS-C SANSARGAJANYA BAHUPITTA KAMALA With SPECIAL REFERENCE TO HEPATITIS C
Sanjeevani Darshan - National Journal of Ayurveda & Yoga · 2026 · 04 (02) · 64-73
DOI: 10.55552/sdnjay.2026.4208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sanjeevani Darshan - National Journal of Ayurveda & Yoga, 2026. Verfasst von Dr. Shubhada Bandsode und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kamala is a Pitta-dominant disorder in Ayurveda characterized by yellow discoloration due to vitiation of Pitta and Rakta, and involving the Yakrit (liver). Sansargajanya Bahupitta Kamala is a severe form associated with other Doshas and is clinically comparable to Hepatitis C. This case study presents a 45-year-old male patient with symptoms like bhrama, aruchi, and udarashoola, diagnosed with Hepatitis C and mild hepatomegaly. The patient was treated with Shamana Chikitsa using classical Ayurvedic formulations along with dietary and lifestyle modifications, aiming at Pittashamana, Amapachana, and restoration of liver function.
Zitieren
APA
Bandsode, D. S., Jaiswal, D. S. K., Jamdhade, D. S. B., & Jamdhade, D. P. (2026). A CLINICAL CASE STUDY OF HEPATITIS-C SANSARGAJANYA BAHUPITTA KAMALA With SPECIAL REFERENCE TO HEPATITIS C. Sanjeevani Darshan - National Journal of Ayurveda & Yoga, 04(02), 64-73. https://doi.org/10.55552/sdnjay.2026.4208
Vancouver
Bandsode DS, Jaiswal DSK, Jamdhade DSB, Jamdhade DP. A CLINICAL CASE STUDY OF HEPATITIS-C SANSARGAJANYA BAHUPITTA KAMALA With SPECIAL REFERENCE TO HEPATITIS C. Sanjeevani Darshan - National Journal of Ayurveda & Yoga. 2026;04(02):64-73. doi:10.55552/sdnjay.2026.4208
BibTeX
@article{Bandsode2026,
author = {Bandsode, Dr. Shubhada and Jaiswal, Dr. S. K and Jamdhade, Dr. S. B and Jamdhade, Dr. Pradnya},
title = {A CLINICAL CASE STUDY OF HEPATITIS-C SANSARGAJANYA BAHUPITTA KAMALA With SPECIAL REFERENCE TO HEPATITIS C},
journal = {Sanjeevani Darshan - National Journal of Ayurveda & Yoga},
year = {2026},
volume = {04},
number = {02},
pages = {64--73},
doi = {10.55552/sdnjay.2026.4208}
}
EUVIMED